A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour

References

• Bichel P., Overgaard J. Hyperthermic effect on exponential and plateau ascites tumour cells in virro is dependent on environmental pH. Radiation Research 1977; 70: 449–454
   PubMed Web of Science ®Google Scholar
• Brown J. M. Exploitation of bioreductive agents with vasoactive drugs. Radiation Research, E. M. Fielden, J. F. Fowler, J. H. Hendry, D. Scott. Taylor & Francis, London 1987; Vol. 2: 719–724
   Google Scholar
• Brown J. M., Twentyman P. R., Zamvil S. S. Response of RIF-1 tumour in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay and tumour control), chemotherapeutic agents and activated macrophages. Journal of the National Cancer Institute 1980; 64: 605–611
   PubMedGoogle Scholar
• Chaplin D. J., Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 579–585
   PubMed Web of Science ®Google Scholar
• Chaplin D. J. Postirradiation modification of tumour blood flow: a method to increase the effectiveness of chemical radiosensitizers. Radiation Research 1988; 115: 292–302
   PubMed Web of Science ®Google Scholar
• Dewey W. C., Hopwooi L. E., Sapareto S. A., Gerweck L. E. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977; 123: 463–474
   PubMed Web of Science ®Google Scholar
• Dunlop F. R. C., Hand J. W., Dickinson R. J., Field S. B. An assessment of local hypcrthcrmia in clinical practice. Internatioanl Journal of Hyperthermia 1986; 2: 39–50
   PubMedGoogle Scholar
• Eddy H. A. Alteration in tumour microvasculature during hyperthermia. Radiology 1980; 137: 515–521
   PubMed Web of Science ®Google Scholar
• Freeman M. L., Dewry W. C., Hopwood L. E. Effect of pH on hyperthermic cell survival. Journal of the National Cancer Instirute. 1977; 58: 1837–1839
   PubMedGoogle Scholar
• Gerweck L. E. Modification of cell lethality at elevated temperatures. The pH eflect. Radiation Research 1977; 70: 224–235
   PubMed Web of Science ®Google Scholar
• Gerweck L. E., Nygaard T. G., Burlett M. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Research 1979; 39: 966–972
   PubMed Web of Science ®Google Scholar
• Gfrweck L. E., Rottinger E. Enhancement of mammalian cell sensitivity to hyperthermia by pH alteration. Radiation Research 1976; 67: 508–511
   PubMed Web of Science ®Google Scholar
• Hahn G. M. Hyperthermia and Cancer. Plenum Press, New York 1982
   Google Scholar
• Hill S. A., Denekamp J. The effect of vascular occlusion on the thermal sensitization of a mouse tunlour. British Journal of Radiology 1978; 51: 977–1002
   Web of Science ®Google Scholar
• Horsman M. R., Christensen K. L., Overgaard J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma. in vivo. International Journal of Hyperthermia 1989; 5: 123–136
   PubMed Web of Science ®Google Scholar
• Jain R. K., Ward-Hartley K. Tumour blood flow - characterization. modifications and role in hyperthermia. IEEE Transactions: Sonics and Ultrasonics 1984; 31: 504–526
   Web of Science ®Google Scholar
• Kallman R. F., Silini G., Van Putten L. M. Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumours. Journal of the National Cancer Institute 1967; 39: 359–549
   Google Scholar
• Kalmus J., Okunieff P., Vaupel P. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumours. Cancer Research 1990; 50: 15–19
   PubMed Web of Science ®Google Scholar
• Lagendijk J. J. W., Mooibroek J. Hyperthermia treatment planning. Recent Results in Cancer Research 1986; 101: 119–131
   PubMedGoogle Scholar
• Meyer K. R., Hopwood L. E., Gillette E. L. The thermal response of mouse adenocarcinoma cells at low pH. European Journal of Cancer 1979; 15: 1219–1222
   Web of Science ®Google Scholar
• Moulder J. E., Rockwell S. Hypoxic fractions of solid tumours: experimental techniques. methods of analysis, and a survey of existing data. International Journal of Radiation Oncology. Biology and Physics 1984; 10: 695–717
   PubMed Web of Science ®Google Scholar
• Myers R., Field S. B. Hyperthermia and the oxygen enhancement ratio for damage to baby rat cartilage. British Journal of Radiology 1979; 39: 73–81
   Google Scholar
• Nfilsen O. S., Overgard J. Effect of extracellular pH on thermotolerance and recovery of hyperthermic daniage. in vitro. Cancer Research 1979; 39: 2772–2778
   PubMed Web of Science ®Google Scholar
• Overgaard J., Bichel P. The influence of hypoxia and acidity on the hyperthermic response of malignant cells. in vitro. Radiology 1977; 123: 511–514
   PubMed Web of Science ®Google Scholar
• Overgaard J., Neilsen O. S. The role of tissue environmental factors on the kinetics and morphology of tumour cells exposed to hyperthermia. Annals of the New York Academy of Sciences 1980; 335: 254–280
   PubMedGoogle Scholar
• Overgaard J. Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis. Cancer 1977; 39: 2637–2646
   PubMed Web of Science ®Google Scholar
• Sapirstein L. A. Regional blood tlow by fractional distribution of indicators. American Journal of Physiology 1958; 193: 161–168
   PubMed Web of Science ®Google Scholar
• Shravistav S., Kaelin W. G., Joines W. T., Jirtle R. Microwave hypertherrnia and its effect on tuniour blood flow in rats. Cancer Research 1983; 43: 4665–4669
   PubMedGoogle Scholar
• Song C. W. Effect of local hypertherrnia on blood flow and microenvironment: a review. Cancer Research, Suppl 1984; 44: 4721s–4730s
   Google Scholar
• Song C. W., Kang M. S., Rhee J. G., Levitt S. H. Vascular damage and delayed cell death in tumours after hyperthermia. British Journal of Cancer 1980; 41: 309–312
   PubMed Web of Science ®Google Scholar
• Song C. W., Patten M. S., Cheistrom L. M., Rhee I. G., Leviit S. H. Effect of multiple heatings on the blood flow in RIF-1 turnours. skin and muscle of C3H mice. International Journal of Hyporthermia 1987; 3: 535–545
   PubMed Web of Science ®Google Scholar
• Stratford I. J., Adams G. E., Godden J., Howells N. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in. vivo. International Journal of Radiation Biology 1989; 55: 411–422
   PubMed Web of Science ®Google Scholar
• Stratford I. J., Adams G. E., Godden J., Nolan J., Howells N., Timpson N. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. British Journal of Cancer 1988; 58: 122–127
   PubMed Web of Science ®Google Scholar
• Twentyman P. R., Brown J. M., Gray J. W., Franko A. J., Scoles M. A., Kallman R. F. A new mwse model tumour system (RIF-1) for comparison of endpoint studies. Journal of the National Cancer Institute 1980; 64: 595–604
   PubMedGoogle Scholar
• Voorhees W. D., Babbs C. F. Hydralazine-enhanced selective heating of transmissible venereal tuniour implants in dogs. European Journal of Cancer and Clinical Oncology 1982; 18: 1027–1033
   PubMedGoogle Scholar
• Wallen C. A., Colby T. V., Stewart J. R. Cell kill and tumour control after heat treatment with and without vascular occlusion in RIF-1 tumours. Radiation Resectrch. 1986; 106: 215–223
   PubMed Web of Science ®Google Scholar
• Walton M. I. The effects of hyperthermia on the pharmacokinetics of selected anticancer drugs. PhD Thesis. figure 3.5. University of Cambridge, UK 1988
   Google Scholar
• Walton M. I., Cattermole D., Bleehen N. M. A microcomputer-controlled, local hyperthermia system for uniform tuniour heating in unanaesthetized mice. International Journal of Hyperthermia 1989; 5: 53–58
   PubMed Web of Science ®Google Scholar